课题基金 / 基金详情

Impact of TLR2/environment interactions on asthma susceptibility: mouse models

Impact of TLR2/environment interactions on asthma susceptibility: mouse models
TLR2/环境相互作用对哮喘易感性的影响:小鼠模型
批准号:
8034754
负责人:
EMANUELA CASTIGLI
金额:
$19.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2012-02-29

项目摘要

项目成果

EMANUELA CASTIGLI的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):哮喘和过敏是一种复杂的疾病,具有强烈的家族性成分,表明遗传易感性。人类TLR2基因座的遗传变异、环境因素及其相互作用与暴露于微生物产物的儿童对哮喘的易感性密切相关。然而,近亲繁殖群体内的遗传异质性阻碍了关联研究揭示哪些变异影响疾病易感性。我们的目标是描述自然变异对人类过敏性炎症发展和易感性关键基因表达和功能影响的机制。我们的模型基因是人类TLR2,它是先天免疫的关键效应因子,也是哮喘和过敏的调节剂。我们发现:(1)人类TLR2变异rs4696480与哮喘和过敏保护密切相关;(2)人类TLR2位点包括与rs4696480相关的其他多态性。我们相信,最终,人类snp需要在生理基因组背景下进行体内研究。在这里,我们希望验证这样一个假设,即人类TLR2遗传变异与导致哮喘易感性的环境暴露之间的相互作用可以在携带哮喘/过敏相关的人类TLR2单倍型的BAC转基因(TG)小鼠中有效地建模和解剖。更具体地说,我们提出:目标1:产生、验证和分析携带人类TLR2基因座单倍型的小鼠TLR2缺陷BAC TG系,这些基因-环境相互作用涉及影响哮喘易感性。这项工作将利用我们对TLR2变异的分析和我们在BAC重组方面的技能,并将引领TG系的产生,这些TG系表现出忠实的组织特异性和拷贝数依赖的人类TLR2表达,但缺乏小鼠TLR2。目的2:确定hTLR2变异与微生物产物暴露之间基因-环境相互作用的机制,并评估其对哮喘/过敏易感性的影响。这项工作将依赖于体外和离体模型,以确定变异是否在转录和/或转录后水平上影响hTLR2的表达和功能。小鼠tlr2缺乏背景将是人类tlr2依赖表型表征的理想选择。通过提供一个可控的遗传背景,我们提出的TG模型将定义与TLR2依赖表型相关的单倍型及其对TLR2表达和/或功能的修饰作用,为旨在中和遗传TLR2/环境影响对哮喘和过敏的影响的策略铺平道路。
英文摘要
DESCRIPTION (provided by applicant): Asthma and allergies are complex diseases with a strong familial component suggestive of a genetic predisposition. Genetic variants in the human TLR2 locus, environmental factors and their interactions are strongly associated with susceptibility to asthma in children exposed to microbial products. However, genetic heterogeneity within outbred populations prevents association studies from revealing which variants affect disease susceptibility. Our goal is to characterize the mechanism(s) underlying the impact of natural variants on the expression and function of genes critical for the development of, and the susceptibility to, human allergic inflammation. Our model gene is human TLR2, a key effector in innate immunity and modulator of asthma and allergy. We showed that: (1) human TLR2 variant rs4696480 is strongly associated with protection against asthma and allergy; (2) the human TLR2 locus includes other polymorphisms linked to rs4696480. We are convinced that, ultimately, human SNPs need to be studied in vivo within a physiologic genomic context. Here we wish to test the hypothesis that the interplay between human TLR2 genetic variation and environmental exposures that results in asthma susceptibility can be effectively modeled and dissected in BAC transgenic (TG) mice carrying asthma/allergy-associated human TLR2 haplotypes. More specifically, we propose: Aim 1: Generation, validation and analysis of murine Tlr2-deficient BAC TG lines carrying human TLR2 locus haplotypes involved in gene-environment interactions that affect asthma susceptibility. This work will capitalize on our analysis of variation in TLR2 and our skills in BAC recombineering, and will lead the generation of TG lines exhibiting faithful tissue-specific and copy number-dependent expression of human TLR2, but lacking murine Tlr2. Aim 2: Identification of the mechanisms underlying gene-environment interactions between hTLR2 variants and exposure to microbial products, and assessment of their impact on asthma/allergy susceptibility. This work will rely on in vitro and ex vivo models in order to determine whether variation acts on expression and functions of hTLR2 at transcriptional and/or post-transcriptional level. The murine tlr2-deficient background will be ideal for the characterization of human TLR2-dependent phenotypes. By providing a controlled genetic background, the TG model we propose will define the haplotypes involved in TLR2-dependent phenotypes and their modifying effects on TLR2 expression and/or function, paving the way for strategies aimed at neutralizing the effects of genetic TLR2/environment impact on asthma and allergies. PUBLIC HEALTH RELEVANCE: The overall goal of our work is to characterize the mechanisms underlying the impact of natural genetic variation and environmental factors on the expression and function of genes critical for the development of, and the susceptibility to, human allergic inflammation. Our model is TLR2, a receptor involved in innate immunity whose genetic variation interacting with microbial products affects the susceptibility to asthma and allergy. We have found that a TLR2 polymorphism, rs4696480, is strongly associated with susceptibility to asthma and allergy in children exposed to microbial molecules. We have performed an extensive analysis of TLR2 variation and identified polymorphisms in linkage with rs4696480. To elucidate the mechanisms involved in the interaction between human TLR2 genetic variation and exposure to microbial products that result in asthma/allergy susceptibility powerful and physiologic approaches are required. Ultimately, polymorphisms need to be studied in vivo within the physiologic genomic context. In this proposal we wish to explore the hypothesis that (1) human TLR2 polymorphisms associated with asthma susceptibility phenotypes are sufficient to induce appreciable alterations of TLR2 expression and/or function in defined and controlled environmental conditions, and (2) the interactions between natural genetic TLR2 variation and environment that affect human TLR2 regulation/function can be effectively modeled and dissected in mouse models carrying defined human TLR2 haplotypes on a murine Tlr2-deficient background. The fact that haplotype/environment patterns affecting TLR2 expression/function are assessed against controlled genetic background, ensures that this in vivo model will allow us to determine which polymorphisms are necessary and sufficient to induce altered TLR2 expression and/or function activity and therefore leading to the molecular mechanisms responsible for TLR2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of TLR2/environment interactions on asthma susceptibility: mouse models
  • 批准号:
    7873077
  • 项目类别:
  • 资助金额:
    $23.15万
  • 财政年份:
    2010
  • 负责人:
    EMANUELA CASTIGLI
  • 依托单位:
APRIL-TACI: role in mucosal IgA and human IgA deficiency
  • 批准号:
    7140244
  • 项目类别:
  • 资助金额:
    $20.63万
  • 财政年份:
    2005
  • 负责人:
    EMANUELA CASTIGLI
  • 依托单位:
APRIL-TACI: Role in mucosal IgA and human IgA deficiency
  • 批准号:
    6956844
  • 项目类别:
  • 资助金额:
    $25.31万
  • 财政年份:
    2005
  • 负责人:
    EMANUELA CASTIGLI
  • 依托单位:
海外基金